Hypozalix spray (artificial saliva)

Phase 2Small molecule

Hypozalix spray (artificial saliva) is one of 18 small molecule programs targeting Xerostomia. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

XerostomiaActive, not recruiting

XerostomiaPhase 2

Active, not recruiting

Competition

Competitive Landscape

38 competitors in Xerostomia

#DrugCompanyPhaseTrials

Isopto Carpine

AAdvanz Pharma

Approved

3 2

Decadron

AAspen Global Incorporated

Approved

—3

Ethyol

LLegacy Health System

Approved

—4

Evoxac

CCosette Pharmaceuticals, Inc.

Approved

1 5

Biotene

UUniversity of Southern California

Approved

1 6

Aloevera

GGovernment Dental College and Research Institute, Bangalore

Phase 3

1 7

Stem Cells

KKang Stem Biotech Co., Ltd.

Phase 2

1 8

Amifostine Trihydrate

GGynecologic Oncology Group

Phase 2

1 9

Mesenchymal Stem Cell

RRohto Pharmaceutical Co., Ltd.

Phase 2

1 10

Platinol

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Xerostomia1 trial

Efficacy of Traditional Persian Medicine Preparation Versus Artificial Saliva for Radiation Induced Xerostomia

Completed·SShiraz University of Medical Sciences·Phase 2·NCT02854358·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Hypozalix spray (artificial saliva). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Hypozalix spray (artificial saliva) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Hypozalix spray (artificial saliva). EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Shiraz University of Medical Sciences company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: SShiraz University of Medical Sciences

Hypozalix spray (artificial saliva)

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Xerostomia1 trial

References

Drug Info

Quick Facts

Related News